Andrew Morton

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersGene and molecular therapySystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2024
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

Matthew J Roberts, Nathan Papa, Hans Veerman

|Mar 17, 2022
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.

Matthew J Roberts, Andrew Morton, Nathan Papa

|Sep 12, 2020
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.

Matthew J Roberts, Andrew Morton, Peter Donato

|Jul 23, 2020
<sup>68</sup>Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.

Matthew J Roberts, Andrew Morton, Peter Donato

|Jun 20, 2020
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data.

Andrew Morton, Michael Williams, Marlon Perera

Pageof 1